Current Management of Chronic Myeloid Leukemia Myeloid Blast Phase.

Chronic myeloid leukemia additional chromosomal abnormality blast crisis stem cell transplant tyrosine kinase inhibitor

Journal

Clinical Medicine Insights. Oncology
ISSN: 1179-5549
Titre abrégé: Clin Med Insights Oncol
Pays: United States
ID NLM: 101525771

Informations de publication

Date de publication:
2022
Historique:
received: 06 07 2022
accepted: 31 10 2022
entrez: 12 12 2022
pubmed: 13 12 2022
medline: 13 12 2022
Statut: epublish

Résumé

Despite the major advancements in the management of chronic phase (CP) chronic myeloid leukemia (CML), blast crisis (BC) remains a major therapeutic challenge. BC can be myeloid, lymphoid, or mixed lineage with myeloid BC being the most common type. BC in CML is mediated by aberrant tyrosine kinase activity of the

Identifiants

pubmed: 36507316
doi: 10.1177/11795549221139357
pii: 10.1177_11795549221139357
pmc: PMC9726842
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

11795549221139357

Informations de copyright

© The Author(s) 2022.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Leuk Res. 2011 Jun;35(6):777-82
pubmed: 21145590
Leukemia. 2011 Jan;25(1):178-81
pubmed: 20962862
Eur J Cancer. 2013 Nov;49(17):3666-70
pubmed: 23968731
Blood. 2018 Jul 26;132(4):393-404
pubmed: 29567798
PLoS One. 2011;6(7):e22110
pubmed: 21760961
Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):244-51
pubmed: 22534616
Acta Haematol. 2020;143(6):567-573
pubmed: 32289808
Blood. 2011 Aug 4;118(5):1208-15
pubmed: 21562040
N Engl J Med. 2006 Jun 15;354(24):2531-41
pubmed: 16775234
N Engl J Med. 2006 Jun 15;354(24):2542-51
pubmed: 16775235
Eur Rev Med Pharmacol Sci. 2021 Dec;25(24):7787-7798
pubmed: 34982440
Cancer. 1999 Dec 15;86(12):2632-41
pubmed: 10594858
Blood. 2009 Jun 18;113(25):6322-9
pubmed: 19369231
Leuk Lymphoma. 2018 Jul;59(7):1659-1665
pubmed: 29179634
Bone Marrow Transplant. 2019 Nov;54(11):1764-1774
pubmed: 30962502
Cancer. 2007 Mar 1;109(5):899-906
pubmed: 17236224
Leukemia. 2020 Apr;34(4):966-984
pubmed: 32127639
Acta Haematol. 2002;107(2):76-94
pubmed: 11919388
Ann Hematol. 2015 Apr;94 Suppl 2:S107-21
pubmed: 25814077
Cancer. 2007 Apr 15;109(8):1543-9
pubmed: 17340589
N Engl J Med. 2006 Dec 7;355(23):2408-17
pubmed: 17151364
Blood. 2009 Sep 3;114(10):2168-71
pubmed: 19589924
J Clin Oncol. 2005 Jun 10;23(17):3948-56
pubmed: 15883410
Am J Hematol. 2015 Sep;90(9):755-68
pubmed: 26040495
Biol Blood Marrow Transplant. 2019 Oct;25(10):2008-2016
pubmed: 31271884
Haematologica. 1991 Sep-Oct;76(5):406-8
pubmed: 1806446
Blood. 2007 Apr 15;109(8):3207-13
pubmed: 17185463
J Clin Oncol. 2005 Jun 20;23(18):4100-9
pubmed: 15867198
Blood Adv. 2020 Oct 27;4(20):5246-5256
pubmed: 33104796
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2794-9
pubmed: 16477019
Haematologica. 2007 Mar;92(3):401-4
pubmed: 17339191
J Hematol Oncol. 2021 Jun 15;14(1):94
pubmed: 34130720
Lancet Oncol. 2007 Mar;8(3):273-4
pubmed: 17329198
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5401-10
pubmed: 25516983
Cancer. 2007 Jan 15;109(2):248-55
pubmed: 17154172
Leukemia. 2016 Jul;30(7):1606-9
pubmed: 26837843
Blood. 2020 Jun 25;135(26):2337-2353
pubmed: 32157296
Am J Med. 1987 Sep;83(3):445-54
pubmed: 3477958
J Clin Oncol. 1986 Jul;4(7):1079-88
pubmed: 3459811
Blood. 2002 Apr 1;99(7):2304-9
pubmed: 11895760
Haematologica. 2008 Dec;93(12):1792-6
pubmed: 18838477
Leuk Lymphoma. 2012 May;53(5):907-14
pubmed: 22023530
Cancer. 2003 Aug 1;98(3):522-8
pubmed: 12879469
Ann Hematol. 2010 Nov;89(11):1099-105
pubmed: 20499235
N Engl J Med. 2001 Apr 5;344(14):1038-42
pubmed: 11287973
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Leuk Lymphoma. 2007 Feb;48(2):283-9
pubmed: 17325887
Lancet Haematol. 2022 Feb;9(2):e121-e132
pubmed: 34906334
Haematologica. 2012 Mar;97(3):473-4
pubmed: 22133777
Bone Marrow Transplant. 2021 Nov;56(11):2834-2841
pubmed: 34331022
Acta Haematol. 2014;132(2):172-6
pubmed: 24603361
Leukemia. 2012 May;26(5):959-62
pubmed: 22157807
N Engl J Med. 2013 Nov 7;369(19):1783-96
pubmed: 24180494
Blood. 2011 Dec 22;118(26):6760-8
pubmed: 22039253
Blood. 2002 May 15;99(10):3530-9
pubmed: 11986204
Blood Cancer J. 2017 Feb 3;7(2):e521
pubmed: 28157214
Blood. 2011 May 26;117(21):e198-206
pubmed: 21346257
Am J Hematol. 2020 Nov;95(11):1288-1295
pubmed: 32681739
Sci Transl Med. 2016 Sep 7;8(355):355ra117
pubmed: 27605552
J Natl Compr Canc Netw. 2020 Oct 01;18(10):1385-1415
pubmed: 33022644
J Clin Oncol. 2009 Sep 1;27(25):4204-10
pubmed: 19652056
Leuk Lymphoma. 2017 Sep;58(9):1-6
pubmed: 28278723
Best Pract Res Clin Haematol. 2016 Sep;29(3):295-307
pubmed: 27839570
Blood. 2002 May 15;99(10):3547-53
pubmed: 11986206
Blood. 2007 Dec 1;110(12):4005-11
pubmed: 17785585
Leuk Lymphoma. 2019 Dec;60(13):3099-3101
pubmed: 31556337
Front Oncol. 2019 Oct 25;9:1132
pubmed: 31709190
J Clin Invest. 2010 Jul;120(7):2254-64
pubmed: 20592475
J Clin Oncol. 2006 Nov 20;24(33):e51-2
pubmed: 17114651
Bone Marrow Transplant. 2012 Jun;47(6):810-6
pubmed: 21986636
Cancer. 2010 Aug 15;116(16):3852-61
pubmed: 20564086

Auteurs

Binoy Yohanan (B)

Department of Hematology/Oncology, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Binsah George (B)

Department of Hematology/Oncology, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Classifications MeSH